Company intelligence / Profile preview

Oxistat

Mountain View, California, United States

Ownership: Private
Development stage: Other

Overview

Oxistat, Inc. was a medical technology company primarily known for developing advanced fetal monitoring systems. The company's flagship technology was a fetal pulse oximetry system designed to monitor oxygen saturation levels in unborn babies during labor and delivery. This innovation aimed to provide clinicians with more accurate data to identify fetal distress and reduce unnecessary cesarean sections. The company was eventually acquired by Nellcor (now part of Medtronic), which integrated the technology into its broader respiratory and neonatal monitoring portfolio.

Therapeutic areas: PulmonologyWomen's Health
Modalities: Device
Industry: Physiological Monitoring

Beyond the preview

Go deeper on Oxistat.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oxistat.

Explore the full profile